SecBot SecBot
144 ·Filed Aug 10, 2026

CMPS

COMPASS Pathways plc
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001959173-26-005811
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine Form 144 filing by a former director for a modest share amount. No immediate trading action is warranted. Monitor for any actual Form 4 filings reflecting completed sales, but this filing alone does not signal insider concern about the company's prospects.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.18
T+0 close · Aug 10, 2026 · via day close
Latest settled
−34.83%
T+60 · $8.59
Vs SPY
−32.41%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 10 $13.18entry
  2. T+1 · 3mo ago +1.52%α +1.84% · $13.38
  3. T+5 · 3mo ago +4.10%α +4.14% · $13.72
  4. T+20 · 2mo ago +6.53%α +7.44% · $14.04
  5. T+60 · 14d ago −34.83%α −32.41% · $8.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former director Annalisa Jenkins filed a Form 144 notice of intent to sell 26,000 American Depositary Shares of COMPASS Pathways, with an estimated aggregate market value of approximately $345,799. The shares were acquired via stock option exercise on the same day. While the filing signals a planned sale by a former board member, the amount is modest relative to the company's $1.9B market cap and Jenkins' remaining holdings (83,771 ADSs still held). No material negative signal is warranted from this routine diversification sale by a non-executive former director.

Key Facts

  • Former director Annalisa Jenkins filed Form 144 to sell 26,000 ADSs of COMPASS Pathways.
  • Estimated aggregate market value of the proposed sale is $345,799.36.
  • Shares were acquired via stock option exercise on August 10, 2026.
  • Jenkins still holds 83,771 ADSs after the proposed sale.
  • The sale represents a small fraction of the company's $1.9B market cap.

Financial Impact

Proposed sale of 26,000 ADSs valued at ~$345,799, representing ~0.02% of market cap.

dilution

Risk Factors

  • The sale may still be completed, adding modest supply to the market.
  • Former director sales can sometimes precede broader insider selling patterns.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-005811
Document: 0001959173-26-005811-index.html0001959173-26-005811
Document: 0001959173-26-005811.txt0001959173-26-005811

Track record

6 reports on CMPS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $8.59 to $9.25 Now $8.27 −3.73% ▲ +7.68% +8.27% vs SPY
  2. Oct 28, 202619d ago SC 13G Neutral 4/10 Entry $12.28 to $8.60 Now $8.27 −32.65% ▼ −29.97% −29.26% vs SPY
  3. Aug 10, 202614w ago 144 Neutral 3/10 Viewing Entry $13.18 to $13.72 Now $8.27 −37.25% ▲ +4.10% +4.14% vs SPY
  4. Aug 5, 202614w ago 8-K Neutral 5/10 Entry $13.58 to $14.22 Now $8.27 −39.10% ▲ +4.71% +4.36% vs SPY
  5. Jul 7, 202618w ago 8-K Neutral 3/10 Entry $12.99 to $13.39 Now $8.27 −36.34% ▲ +3.08% +2.53% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $11.41 to $11.94 Now $8.27 −27.52% ▲ +4.64% +4.21% vs SPY
Showing 6 of 6

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026